0byt3m1n1
Path:
/
home
/
artemisi
/
mail
/
.Trash
/
cur
/
[
Home
]
File: 1628698427.M314069P22415.cp05.machighway.com,S=3409,W=3487:2,S
Return-Path: <> Delivered-To: artemisi@cp05.machighway.com Received: from cp05.machighway.com by cp05.machighway.com with LMTP id WNQvNfAG/1xnUQAAO6ibsw (envelope-from <>) for <artemisi@cp05.machighway.com>; Tue, 11 Jun 2019 01:42:08 +0000 Return-path: <> Envelope-to: artemisi@cp05.machighway.com Delivery-date: Mon, 10 Jun 2019 21:42:08 -0400 Received: from mailnull by cp05.machighway.com with local (Exim 4.92) id 1haVnc-0005V3-Ox for artemisi@cp05.machighway.com; Mon, 10 Jun 2019 21:42:08 -0400 X-Failed-Recipients: kirtanadmin@shubalananda.com Auto-Submitted: auto-replied From: Mail Delivery System <Mailer-Daemon@cp05.machighway.com> To: artemisi@cp05.machighway.com Content-Type: multipart/report; report-type=delivery-status; boundary=1560217328-eximdsn-1201637173 MIME-Version: 1.0 Subject: Mail delivery failed: returning message to sender Message-Id: <E1haVnc-0005V3-Ox@cp05.machighway.com> Date: Mon, 10 Jun 2019 21:42:08 -0400 --1560217328-eximdsn-1201637173 Content-type: text/plain; charset=us-ascii This message was created automatically by mail delivery software. A message that you sent could not be delivered to one or more of its recipients. This is a permanent error. The following address(es) failed: kirtanadmin@shubalananda.com No Such User Here --1560217328-eximdsn-1201637173 Content-type: message/delivery-status Reporting-MTA: dns; cp05.machighway.com Action: failed Final-Recipient: rfc822;kirtanadmin@shubalananda.com Status: 5.0.0 --1560217328-eximdsn-1201637173 Content-type: message/rfc822 Return-path: <artemisi@cp05.machighway.com> Received: from artemisi by cp05.machighway.com with local (Exim 4.92) (envelope-from <artemisi@cp05.machighway.com>) id 1haVnc-0005Uy-K5 for kirtanadmin@shubalananda.com; Mon, 10 Jun 2019 21:42:08 -0400 To: kirtanadmin@shubalananda.com Subject: [Shubalananda Kirtan] Please moderate: "Welcome to the new Shubalananda Kirtan website!" X-PHP-Script: shubalananda.com/wp-comments-post.php for 166.62.84.121 Date: Tue, 11 Jun 2019 01:42:08 +0000 From: WordPress <wordpress@shubalananda.com> Message-ID: <ab38ea68bed1de6b35d426bf30599fbb@shubalananda.com> X-Mailer: PHPMailer 5.2.22 (https://github.com/PHPMailer/PHPMailer) MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8 A new comment on the post "Welcome to the new Shubalananda Kirtan website!" is waiting for your approval http://shubalananda.com/2017/09/25/welcome-to-the-new-shubalananda-kirtan-website/ Author: Cedric (IP address: 166.62.84.121, ip-166-62-84-121.ip.secureserver.net) Email: moises3z@usa.net URL: http://beeg.in.net/ Comment: What do you do for a living? http://femjoy.in.net/ femjoy A federal advisory panel recommended approval ofGlaxoSmithKline's new drug to treat chronic obstructivepulmonary disease (COPD), but suggested the company be requiredto conduct further safety studies once the drug is approved. GSKis developing the product with Theravance. Approve it: http://shubalananda.com/wp-admin/comment.php?action=approve&c=17#wpbody-content Trash it: http://shubalananda.com/wp-admin/comment.php?action=trash&c=17#wpbody-content Spam it: http://shubalananda.com/wp-admin/comment.php?action=spam&c=17#wpbody-content Currently 9 comments are waiting for approval. Please visit the moderation panel: http://shubalananda.com/wp-admin/edit-comments.php?comment_status=moderated#wpbody-content --1560217328-eximdsn-1201637173--